In November 2013 I gave a
presentation called Fiction-Non-Fiction
at the 5th International Artsof Good Health and Wellbeing International Conference in Sydney. In July
2014 I revisited the same train of thought for a conference aimed at Public
Health colleagues at Loughborough University organised by Creative Health. At
this Collaborating in Quality Arts in
Public Health for the Future event, I had in the back of my mind some ideas,
not only about quality – but authenticity – in arts/health. In part, this was as a
response to many of the pompous and grandiose claims made by some in the field
who seem more like marketeers hitching a ride on the well-being bandwagon and
seeing arts/health as a useful vehicle to sell their philosophies. It
was equally a clarion call to those of us who are deeply embedded in this
work, not to be suckered into a reductivist mindset, and perhaps take note of
Mike White’s many illuminating blog-postings, which to me, offer the epitome of
authenticity and offer polar opposites to the quick-fix pseudo-scientists. Having had
a number of requests for Fiction-Non-Fiction
as an essay, I offer it up here in all its grizzly glory, warts and all. So
make what you will of it, typos, grammatical errors and my use of other
people’s brilliance!
FICTION-NON-FICTION (revisited)
When Charles-Edward Winslow defined public health in 1920, he referred
to the science and art of preventing disease; of education; of social machinery
and realising birth rights: all things that require knowledge, political
advocacy and imagination. I’d like to develop some of those ideas and think
about this arts and public health agenda in terms of Winslow’s definition.
In 1966 an album called Symposium in Blues, produced by the
pharmaceutical giant Merk, was distributed to tens of thousands of general
practitioners in the USA, marketing their new anti-depressant, Elavil. That an
album of predominantly black musicians was being used to sell an
anti-depressant was a cynical piece of marketing, considering that African
Americans accounted for high numbers of patients detained in mental health
units and prisons across the US. At that same time, the largest epidemiological
study of mental illness ever conducted in the United States, the National
Institute of Mental Health’s Epidemiologic Catchment Area (ECA) Study,
evidenced striking racial differences in anxiety disorders.
With inequalities in mind and much of our lives mediated by marketing,
I want to think about evidence in arts/health, and ask, just what is the
evidence we are after, who is it for, and who controls it?
Austin Bradford Hill was the statistician on the Medical Research Council’s, Streptomycin in Tuberculosis Trials in 1948 and their study, is generally accepted as the first randomised clinical trial. GP Ben Goldacre in his book Bad Pharma, mischievously reminds us however, that the first recorded control trial was in fact reported in the apocalyptic Book of Daniel.
Austin Bradford Hill was the statistician on the Medical Research Council’s, Streptomycin in Tuberculosis Trials in 1948 and their study, is generally accepted as the first randomised clinical trial. GP Ben Goldacre in his book Bad Pharma, mischievously reminds us however, that the first recorded control trial was in fact reported in the apocalyptic Book of Daniel.
Daniel rejects the royal feasts of invading King Nebuchadnezzar, preferring
to eat with the servants, suggesting that they are given nothing but vegetables
and water for 10 days, after which they looked healthier and better nourished
than those who ate the royal food. Of course the fine food and wine is taken
away, and the nobility are given the Old Testament version of five-a-day. For a
religious parable, this is a million miles away from parting seas and miracle
cures.
I’d argue that what we consider to be authentic and true is so deeply
influenced by the pull of science and religion that it often blinds us to the
truth in the name of a higher power - that higher power might be supernatural,
it might be scientific - and in both cases, it is sophisticatedly marketed,
making it near impossible for us to separate fiction from non-fiction.
As early as 500 B.C., Pythagoras was accepting or rejecting his
students based on how gifted they looked. Aristotle wrote that large-headed
people were mean, those with small faces were steadfast, broad faces reflected
stupidity, and round faces signalled courage. This very classical notion of Physiognomy
and assessing character and morality from outer appearance would now be
described as a pseudoscience, but for centuries, as scientists searched for
tangible, external clues to internal temperaments, appearance has been studied
‘robustly’.
Whilst the term physiognomy no longer resonates, physical appearance
as moral indicator lives on, though our consumer-driven world has increasingly
substituted clothing and material possessions as signifiers of character and we
continue to label people. Your skin colour, or trappings of faith, can still
get you stopped on the street for looking
suspicious.
Physiognomy is a pseudo-science and is ugly and often racist, but
perhaps we can understand its roots - the
urge to classify and make sense of the world. In its time and place, it
seemed to be the cutting edge of thinking.
2013 saw the fifth edition of the Diagnosticand Statistical Manual of Mental Disorders (DSM) published. This informs
the way psychiatrists prescribe drugs and classifies those rich differences in
our interior landscape.
•Excessive eating
will become 'binge eating disorder'
•If you are too
keen on checking emails, perhaps you have maybe suffering from 'internet
addiction'
•Is your house to
messy? You may have ‘Hoarding Disorder’
Whilst being gay is still seen as a moral sin in some parts of the
world, punishable by execution, at least psychiatry has loosened its grip on
classifying homosexuality as a mental disorder, treatable by medication and
aversion therapy.
Former chair of the DSM task force, Dr. Allen Frances, has said that he
believes in the power of psychiatric treatment, but he’s concerned that: “Drug
companies take marketing advantage of the loose DSM definitions by promoting
the misleading idea that everyday life problems are actually undiagnosed
psychiatric illness caused by a chemical imbalance and requiring a solution in
pill form,”
And through this
classification of our interior landscape, we are inevitably open to new and
increasingly sophisticated technology, and nowhere is this more prevalent than
the burgeoning field of neuroscience and the exploration of the human psyche.
There are 85bn neurons
in the average 3lb human brain. Typically, each neuron forms 10,000
connections, through synapses with other nerve cells. Jeff Lichtman's
laboratory at Harvard University has an automatedtape-collecting lathe ultramicrotome (Atlum) which over 6 days, transforms
a 1mm thick slice of brain into around 30,000 slices. He estimates there are
between 100tn and 1,000tn connections between neurons. Lichtman has calculated
how long it might take to image every slice of a 1cm mouse brain. The answer is 7,000 years! This is big data indeed.
Our current obsession
with neurology might be tempered by lessons on authenticity from earlier
experiments. Following Lenin’s death, his brain was dissected into 31,000
pieces, with researchers concluding that it showed an ‘extraordinary degree of
organisation,’ when compared to an ‘ordinary brain’.
Phil Hanlon et al in Perspectives in Public Health argues
that, “faith in science has morphed into an ideology best called ‘scientism’.
Under scientism, what really matters is that which can be supported by
evidence, can be counted or measured and, above all, can be shown to be value
for money. Concerns about evidence and value for money are important, but can
cause problems when taken too far,” particularly, he notes, “if metrics are
used as the sole measure of success.”
What a powerful tool
this big data would be in the hands of people with vested commercial interests,
or even worse those who have the desire to manipulate who we are.
This arts and health
movement that we are part of is growing exponentially and as a consequence, it
attracts not only those of us actively involved in the field, but
free-marketers’ with their eye on either a quick-buck, or perhaps a
standardised tool-kit where all the nuance and complexity of culture and the
arts can be packaged into a small, instrumental, do-it-yourself kit. A one
size-fits-all panacea that can be branded and sold on.
It’s frequently
asserted, that the only way we can prove our efficacy is through robust Randomised Controlled Trials (RCT) more often than not, holding up the pharmaceutical
model as gold standard. I want to think about this conflation for a moment. Thanks
to the forensic work of the GP Ben Goldacre, I’ll share some of the reasons why
I feel a little unrest at the assertion that the arts/health movement somehow
adopts the clinical objectivity of the pharmaceutical industry.
In 2013 GlaxoSmithKline
(GSK) were found guilty of promoting two drugs for unapproved uses and failing
to report safety data to the Food and Drug Administration (FDA) and fined $3bn
- the largest healthcare fraud settlement
in US history. Amongst other things,
GSK has admitted to promoting antidepressants for unapproved uses, including
treatment of children and adolescents, until a ban in 2003, over concerns it
triggered suicides.
A bribery investigation
is underway in China, alleging that GSK, has orchestrated payments - said to
total £321million - offering amongst other things, prostitutes to doctors to
persuade them to prescribe its medicines, allegedly pushing up the prices
Chinese patients pay for GSK drugs by as much as 30%.
Goldacre asserts that
the pharmaceutical industry spends around twice as much on marketing and
promotion as it does on research and development, much of it paid to
high-esteem academic ghostwriters for pharmaceutical driven scientific
journals. He suggests that this kind of fraud and deception isn’t limited to
GSK - far from it, it is endemic across the pharmaceutical industry, with “66%
of fraud cases in the US involving the pharmaceutical industry.”
At the moment, in the
UK, even the National Institute for
Health and Care Excellence who make judgements based on evidence, have no
access, and no legal right to any withheld clinical data.
Thomas Carlyle
described economics as the dismal science, and a narrow focus solely on the
arts saving the health sector money, neglects a nuanced understanding of
cultural value across society. Health and wellbeing are best promoted and
protected in the very communities we live and breathe in, not necessarily the
places we go to when we’re sick. And there is a danger inherent in our
field of work, through the conflation of art and public good, we run the risk
of reducing creativity to an economic unit - a crude commodity -nothing more.
For a twisted
understanding of the fiscal value of the arts, we could perhaps look to the
spiralling prison population in the US, where the government have developed a
simple algorithm to calculate how many new prison cells are they going to need
in 15 years time - find out what
percentage of children aged 10 - 11 can read today. In fact, female
literacy is a significant determinant of health, and Secretary-General of the
UN, Ban Ki-moon has stressed the transformative effect on both a family and the
wider community when a woman is literate. He comments, “By acquiring literacy,
women become more economically self-reliant and more actively engaged in their
country’s social, political and cultural life. All evidence shows that
investment in literacy for women yields high development dividends.”
Albert Einstein, when
asked how we could make our children more intelligent replied, "If you
want your children to be intelligent, read them fairy tales. If you want them
to be more intelligent, read them more fairy tales." He understood
the value of both reading, and the imagination. Author Neil Gaiman reminds us,
“It is easy to pretend that nobody can change anything, that we are in a world
in which society is huge and the individual is less than nothing, but the truth
is, individuals change their world over and over, individuals make the future,
and they do it by imagining that things can be different.”
And boy, do we need to
change the system. The UK has witnessed the exposure of abuse in health and
social care, evidenced most harrowingly in systemic neglect within the NHS.
The Francis Report
identified a target obsessed culture, that
“focused on doing the system’s business - and not that of the patients,’
{…} ‘an institutional culture which ascribed more weight to {…} methods of
measuring compliance (and) which did not focus on the effect of a service on
patients”.
It seems that our
obsession with targets within health and social care, has blinded us to the
very people we should be caring for and the all-prevailing ‘management culture’
that dominates this sector is mirrored in the arts and cultural sector too.
The Artist David
Pledger, in his recent paper for Currency House - Re-evaluating the artist in the new world order, provides us with
a compelling critique of the systems that have seen more money put into
marketing and management that into artists, with the artist being at the very
bottom of the food chain.
Yet shouldn’t the
artist be at the heart of public debate? Scrutinizing, curious and enabling -
questioning dominant ideologies and giving voice to those most marginalised by
those in power? Pledger astutely suggests that ‘managerialism sees itself as
the antidote to chaos, irrationality, disorder, and incompleteness,’ - but
aren’t these the essential elements that are central to the arts?
The research of Gary
Andsell of Nordoff Robbins, shares the intimacy of what Goethe described as gentle empiricism, stressing that ‘our
research should always strive to “save the phenomenon”, never reducing, or
replacing it with an explanation that omits human experience and its
involvement in any understanding.’
Evaluation potentially confers power to justify big decisions, and RayPawson, Professor of Social Research Methodology at the University of Leeds,
playfully suggests that, “mainstream science does not use RCTs. What proper
scientists do is marshal theories and come up with all manner of ingenious empirical
tests of those theories, which go on to refine the original ideas. Other groups
add further tests to develop the explanation.”
I like this and I like Pawson’s assertion that “interventions are not
‘treatments’. Interventions are complex
process introduced into complex
environments attempting to deal with complex
problems. It is impossible to control for every contingency as the
trialists urge”.
We are constantly told
what constitutes robust evidence and more often than not, the model the RCT is held
up as the Gold Standard. I don’t doubt its place at all in science and
medicine, but I have grave concerns for our understanding of RCT’s when
conflated with profit-driven and dishonest industry.
Perhaps the richest
example of distorted evidence held up as unequivocal fact, is the UK
Governments briefing report to Tony Blair in 2003. Now known
as the Dodgy Dossier, we know, that much of the intelligence material was
plagiarised from the graduate student, Ibrahim al-Marashi, only plagiarised
with dangerous amendments designed to justify war.
From physiognomy to big
pharma and political spin - what constitutes evidence, has never felt more
contested. In terms of GDP, Philosopher, Vandana Shiva reflects that “a
living forest does not contribute to growth, but when trees are cut down and
sold as timber, we have growth. Healthy societies and communities do not
contribute to growth, but disease creates growth through the sale of patented
medicines”. This is a distorted
understanding of progress.
She warns us that “the privatisation
of health and education generates growth through profits, but it also generates
poverty by forcing people to spend large amounts of money on what was
previously available at affordable costs, as a common good. When every aspect of
life is commercialised and commoditised,” she suggests, “living becomes more
costly, and people become poorer”.
The challenge for us
now, is to confidently theorise - to explore where we believe the potency of
the arts lies - but in the current financial climate, do we want to be part of
what Vandana Shiva describes as anti-life economics? In the face of
unethical offers from bad-sponsors, can we assert ourselves with integrity? I’m
thinking here of GSK’s annual ‘Impact Awards”, cynically marketed to an
impoverished arts/health sector.
Whilst
imaging our brains might offer up tantalising glimpses of how the essence of
human can be nurtured, enhanced and manipulated - the true complexity of what
we are, and how we engage with each other and our environment - is far more
nuanced.
If we galvanise our
imaginations, and envisaged our work beyond the confines of the neatly
categorised sick individual, we could
truly be a powerful force for social change and justice. And there’s something
of a punk sensibility to the arts, from Pussy-Riot performing in Moscow, to the
2013 12th Youth Performing Arts Festival in Lahor, that despite being bombed in
2008, continues to encourage girls to take part in contemporary theatre.
Tim Lang and Geof Rayner
in their article on Ecological Public Health in the British Medical Journal,
ask how can we “reframe thinking about mental health, social exclusion, and
inequalities in health”, without placing democracy at the heart of our
thinking, where people have “a sense of - and actual engagement in shaping
society and life, particularly when, we live in a “world in which so many
people are excluded from control.”
Isaac Newton in his
book, The Principia wrote what is still considered to be one of the most
important scientific books ever written. And not just because it set out
revolutionary hypotheses about physical laws, but because it set the ‘gold
standard’ in scientific writing. Interestingly, the post war economist and
first chair of Arts Council England, John Maynard Keynes, described Newton, as ‘Not
the first of the age of Reason. He was the last of the magicians’. I do like this
economist’s reflection on the revolutionary magic of Newton’s scientific
imagination.
I’d like to conclude my
presentation, not with answers to questions around the value of our work, but
with some points to consider:
1: SCIENTISM: NancyCartwright for the LSE suggests that “...there is no gold standard; no
universally best method. Gold methods however, are whatever methods will
provide the information you need, reliably, from what you can do, and from what
you can know on the occasion.”
2: ECONOMICS: Hasan
Bakhshi notes in his essay Beauty: valuebeyond measure? even- “...the Treasury’s Green Book guidelines for
cost-benefit analysis...recommends that a range of techniques be used to elicit
non-market values, even if these are subjective. Methods like Social Return On Investment may offer
compelling economic proxies.
3: CULTURAL VALUE: Dr
Samuel Ladkin: in Against Value in the Arts - suggests, “It is often the staunchest defenders of art who
do it the most harm, by suppressing or mollifying its dissenting voice, by
neutralizing its painful truths, and by instrumentalising its potentiality, so
that rather than expanding the autonomy of thought and feeling of the artist
and the audience, it makes art self-satisfied…”
I began with Charles-Edward
Winslow’s assertion that public health is dependent on KNOWLEDGE, POLITICAL ADVOCACY and
critically, IMAGINATION.
To Winslow’s definition,
I would like to add AUTHENTICITY. I think we have some fundamental questions to
explore, and central to this is why we do, what we do, and believe in what we
believe? In our unequal and market-driven world, can we learn from the past to
influence our futures - and is there a danger that if we understand impacts of
the arts in terms of deficit and disease and not assets and potential, we may
just become another pseudo-science? The arts have the power to change mindsets
and challenge outrageous inequalities - and just how we evidence this reach,
might best be understood through the very practice itself.
Brilliant Clive. I think there could be mutualism between the science and the stories and between quantitative and qualitative researchers. But we shouldn't be made to undertake clinical trials unless we are directly asserting that that our intention is to make a clinical difference, in which case, practitioners are accountable within a clinical framework. At the end of the day. commissioning and context will determine the type of evidence required - there shouldn't be a one size fits all expectation. Brilliant, thought provoking stuff Clive!
ReplyDelete